Third treatment option
However, he is PI for a clinical trial opening in a few days that is specifically for recurrent endometrial cancer. Since other treatments are really just adopted from ovarian cancer treatments, one that is for my cancer may be worth giving it a shot. I can always leave the trial and go with carbo or back to tamoxifen if I have concerns. Also, there will be careful monitoring with scans every 8 weeks. I will be randomly assigned to either oral daily tabs or weekly IV infusions. There is no standard care arm, all participants will receive investigative drug.
Annie
Comments
-
Annie
I'm not sure I understand. Would this option continue the tamoxifen and then add the investigative drug during the trial?
Have you decided which option to choose? Is this a hard decision for you?
When you decide, I would like to know your thought process.
Hugs and blessings, Mary Ann0 -
A day later...what are your thoughts?
Somehow, the fact that your primary gyn-onc refuses to equate "aggressive" and "effective" makes sense to me. The clinical trial sounds promising; and the fact that you can always leave it and start on the other treatment options seems like a win-win proposition. How are you feeling about your options at this point? What is your gut telling you?
As always, I am thinking about you with much fondness and concern.
Jill0 -
Well i was rejected by
Well i was rejected by Pfizer for the trial because of 2 doses of Doxil i had for first recurrence before my Dr switched me to Gemzar. The change was made due to side effects i had to Doxil and I tolerated the Gemzar quite well. Pfizer insisted on calling it a third chemo regimen. The first was carbo/taxol after surgery.
I have an appt to revisit/review options with my gyn-onc next week. The more i consider prior outcomes to chemo I am less inclined to jump back in. My breast cancer recurred following chemo - so it obviously didn't kill all the leftover cancer cells post-surgery. Since my UPSC debulking surgery removed all visible cancer, chemo was to get any leftover cells, but it came back. After chemo for recurrences, which reduced ca125 to normal and nothing showed on scans, it wasn't long before it was back. Both gyn-oncs i have consulted with consider endometrial recurrences to be very difficult to manage and note that the only real chemo treatment options are from ovarian cancer protocols. My gyn-onc's plan with tamoxifen may well be my best plan. The worst issue is the resistance to chemo these remaining cancer cells develop. All those wonderful anticancer regimens may be an even more significant part of our therapy.
Thank you all for your kind thoughts and support!! it's most appreciated.
Annie0 -
Here is link on Clinicalartist49 said:clinical trial for endometrial cancer
Could you please tell us the number of this new trial? Thanks
NCT01420081
Here is link on Clinical Trials website:
http://clinicaltrials.gov/ct2/show/NCT01420081?term=b1271004&rank=10 -
Arimidexsnowbird_11 said:Well i was rejected by
Well i was rejected by Pfizer for the trial because of 2 doses of Doxil i had for first recurrence before my Dr switched me to Gemzar. The change was made due to side effects i had to Doxil and I tolerated the Gemzar quite well. Pfizer insisted on calling it a third chemo regimen. The first was carbo/taxol after surgery.
I have an appt to revisit/review options with my gyn-onc next week. The more i consider prior outcomes to chemo I am less inclined to jump back in. My breast cancer recurred following chemo - so it obviously didn't kill all the leftover cancer cells post-surgery. Since my UPSC debulking surgery removed all visible cancer, chemo was to get any leftover cells, but it came back. After chemo for recurrences, which reduced ca125 to normal and nothing showed on scans, it wasn't long before it was back. Both gyn-oncs i have consulted with consider endometrial recurrences to be very difficult to manage and note that the only real chemo treatment options are from ovarian cancer protocols. My gyn-onc's plan with tamoxifen may well be my best plan. The worst issue is the resistance to chemo these remaining cancer cells develop. All those wonderful anticancer regimens may be an even more significant part of our therapy.
Thank you all for your kind thoughts and support!! it's most appreciated.
Annie
Annie, has your doctor mentioned Arimidex to you, as an alternative to Tamoxofen? It is an aromatase inhibitor and apparently blocks hormones that Tamoxofen does not (that is putting it VERY simplistically).
Sending good thoughts
JoAnn0 -
Clinical Trialsnowbird_11 said:Well i was rejected by
Well i was rejected by Pfizer for the trial because of 2 doses of Doxil i had for first recurrence before my Dr switched me to Gemzar. The change was made due to side effects i had to Doxil and I tolerated the Gemzar quite well. Pfizer insisted on calling it a third chemo regimen. The first was carbo/taxol after surgery.
I have an appt to revisit/review options with my gyn-onc next week. The more i consider prior outcomes to chemo I am less inclined to jump back in. My breast cancer recurred following chemo - so it obviously didn't kill all the leftover cancer cells post-surgery. Since my UPSC debulking surgery removed all visible cancer, chemo was to get any leftover cells, but it came back. After chemo for recurrences, which reduced ca125 to normal and nothing showed on scans, it wasn't long before it was back. Both gyn-oncs i have consulted with consider endometrial recurrences to be very difficult to manage and note that the only real chemo treatment options are from ovarian cancer protocols. My gyn-onc's plan with tamoxifen may well be my best plan. The worst issue is the resistance to chemo these remaining cancer cells develop. All those wonderful anticancer regimens may be an even more significant part of our therapy.
Thank you all for your kind thoughts and support!! it's most appreciated.
Annie
Sorry to hear you were rejected. I imagine the clinical trials target a very specific group of people.
Hoping your follow up visit goes well.
Take Care,
Pat0 -
Oops-double postsnowbird_11 said:Well i was rejected by
Well i was rejected by Pfizer for the trial because of 2 doses of Doxil i had for first recurrence before my Dr switched me to Gemzar. The change was made due to side effects i had to Doxil and I tolerated the Gemzar quite well. Pfizer insisted on calling it a third chemo regimen. The first was carbo/taxol after surgery.
I have an appt to revisit/review options with my gyn-onc next week. The more i consider prior outcomes to chemo I am less inclined to jump back in. My breast cancer recurred following chemo - so it obviously didn't kill all the leftover cancer cells post-surgery. Since my UPSC debulking surgery removed all visible cancer, chemo was to get any leftover cells, but it came back. After chemo for recurrences, which reduced ca125 to normal and nothing showed on scans, it wasn't long before it was back. Both gyn-oncs i have consulted with consider endometrial recurrences to be very difficult to manage and note that the only real chemo treatment options are from ovarian cancer protocols. My gyn-onc's plan with tamoxifen may well be my best plan. The worst issue is the resistance to chemo these remaining cancer cells develop. All those wonderful anticancer regimens may be an even more significant part of our therapy.
Thank you all for your kind thoughts and support!! it's most appreciated.
Annie
Hate when I do that!0 -
Annie sorry to hear you were rejected for the clinical trialsnowbird_11 said:Well i was rejected by
Well i was rejected by Pfizer for the trial because of 2 doses of Doxil i had for first recurrence before my Dr switched me to Gemzar. The change was made due to side effects i had to Doxil and I tolerated the Gemzar quite well. Pfizer insisted on calling it a third chemo regimen. The first was carbo/taxol after surgery.
I have an appt to revisit/review options with my gyn-onc next week. The more i consider prior outcomes to chemo I am less inclined to jump back in. My breast cancer recurred following chemo - so it obviously didn't kill all the leftover cancer cells post-surgery. Since my UPSC debulking surgery removed all visible cancer, chemo was to get any leftover cells, but it came back. After chemo for recurrences, which reduced ca125 to normal and nothing showed on scans, it wasn't long before it was back. Both gyn-oncs i have consulted with consider endometrial recurrences to be very difficult to manage and note that the only real chemo treatment options are from ovarian cancer protocols. My gyn-onc's plan with tamoxifen may well be my best plan. The worst issue is the resistance to chemo these remaining cancer cells develop. All those wonderful anticancer regimens may be an even more significant part of our therapy.
Thank you all for your kind thoughts and support!! it's most appreciated.
Annie
I know it must be disappointing for you. You remain in my thoughts and prayers. In peace in caring. Hope you can contnue to enjoy each day.0 -
Hope you decide a plan soonsnowbird_11 said:Well i was rejected by
Well i was rejected by Pfizer for the trial because of 2 doses of Doxil i had for first recurrence before my Dr switched me to Gemzar. The change was made due to side effects i had to Doxil and I tolerated the Gemzar quite well. Pfizer insisted on calling it a third chemo regimen. The first was carbo/taxol after surgery.
I have an appt to revisit/review options with my gyn-onc next week. The more i consider prior outcomes to chemo I am less inclined to jump back in. My breast cancer recurred following chemo - so it obviously didn't kill all the leftover cancer cells post-surgery. Since my UPSC debulking surgery removed all visible cancer, chemo was to get any leftover cells, but it came back. After chemo for recurrences, which reduced ca125 to normal and nothing showed on scans, it wasn't long before it was back. Both gyn-oncs i have consulted with consider endometrial recurrences to be very difficult to manage and note that the only real chemo treatment options are from ovarian cancer protocols. My gyn-onc's plan with tamoxifen may well be my best plan. The worst issue is the resistance to chemo these remaining cancer cells develop. All those wonderful anticancer regimens may be an even more significant part of our therapy.
Thank you all for your kind thoughts and support!! it's most appreciated.
Annie
It must be so difficult to try to decide the next path to take. I can understand your initial reaction to want to hit this hard and fast but then to think about previous experiences with chemo and wonder whether that is the best long term route. I am so sorry the trial wasn't for you (the inclusion criteria on these trials is always very strict). My oncologist rates hormone treatment highly for re-recurrences and suggested that it might be the route for me should I get another one, although mine is the more "common" EC and we know that it is ER/PR positive.
Hope you find a way forward soon.
Helen0 -
So sorry..
...that the clinical trial wasn't an option, but I have high hopes for you with the Tomoxifen treatment and you can always switch to a more aggressive option if it doesn't work, but if it does, you saved yourself the hell of full on chemo assault.
Take care,
Cindy0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards